25
Jan
2017
16:00
GMT
Webinar
Morphological and Functional Evaluation for Complex PCI
-
Views:
2035 -
Likes:
0
Overview
This webinar is intended to educate interventional cardiologists and cathlab staff on the importance of morphological and functional assessment to optimize patient treatment strategy in complex PCI.
Clinical case scenarios will cover:
- Why it is important to use functional assessment in patients with intermediate, tandem, diffuse and multivessel Coronary Artery Disease and the evidence that supports this strategy.
- An introduction to iFR and resting indices, and the hybrid approach combining iFR and FFR.
- Scenarios where iFR adds value to FFR alone in multiple lesions and myocardial bridges.
- A forward look towards the importance of ongoing clinical trials - Syntax II, Define FLAIR and iFR -Swedeheart
- The role of IVUS in complex lesion type beyond Left Main
Faculty:
Giuseppe Tarantini
This webinar is supported by
Educational Objectives
This webinar is intended to inform and educate cardiologists on:
- The clinical value of Morphological and Functional assessment in patients with complex coronary disease: multivessel, multilesions, left main and myocardial bridges
- The tools that are available to determine if ischemia is present in patients with intermediate, tandem, diffuse and multivessel CAD
Target Audience
- Interventional Cardiologists
- Interventional Fellows
- Cathlab Nurses and Managers
Faculty Biographies
Giuseppe Tarantini
Prof Giuseppe Tarantini is the Head of the Interventional Cardiology Unit within the Department of Cardiac, Thoracic, and Vascular Sciences at the University of Padua Medical School, Padua, IT. He is a globally recognised researcher specialising in ischemic heart disease, structural heart disease, and cardiomyopathies.
Prof Tarantini serves as the primary operator for a diverse array of interventional procedures, encompassing coronary interventions (including atherectomies), peripheral interventions (such as carotid and renal procedures), and structural heart interventions (involving ASDs, PFOs, TAVI, and AVP).
In addition to his clinical work, Prof Tarantini is a distinguished faculty member at various international conferences, including Transcatheter Cardiovascular Therapeutics (TCT), the Congresso della Societa Italiana di Cardiologia Invasiva (SICI-GISE), Euro PCR, and the European Society of Cardiology (ESC). He boasts a publication record of 245 clinical papers and actively contributes as an editorial board member and reviewer for esteemed journals.